As of April 18, 2025, Valerio Therapeutics SA (ALVIO.PA) has a market cap of $12.072 million USD. According to our data, Valerio Therapeutics SA is ranked No.8745 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $12.07 M |
-8.27%
|
Dec 31, 2024 | $13.16 M |
-54.55%
|
Dec 29, 2023 | $28.95 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.67 B |
-0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.70 B |
-0.000 M
|
![]() Netherlands
|
![]() Voyager Therapeutics
VYGR
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$52.96 M |
-0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
Market Cap | = | ALVIO.PA Stock Price | * | ALVIO.PA Shares Outstanding |
= | $0.08 | * | 0.15 B | |
= | $12.07 M |